All You Need Is LUV
These days there are many innovative drug delivery systems but none of them are as customisable as liposomes.
In the sixties, it was observed that when phospholipids are introduced in water, microparticles (smaller than 10 µm) tend to form. These particles are actually vesicles, a bilayer membrane containing a liquid solution: an ideal environment for many drugs.

The great thing about liposomes is that they are 100% biocompatible and, thanks to their size, can be injected.
Very practical. A liposome can not only carry hydrophilic substances, but lipophilic molecules too: these drugs will interact with the lipophilic chains of the phospholipids. Amphiphilic substances, unsurprisingly, can be easily loaded in a liposome as well.
So many options lead to four different kinds of release: a drug can diffuse away from the vesicle, pass in the aqueous medium and finally enter the target cell following its gradient. The liposome can undergo endocitosis. Whenever the drug tightly binds to the phospholipids, this can be introduced in a cell through lipids exchange between liposome and cell. Finally, a liposome can release its content in the cell as a result of a membrane fusion.
Like the membrane of our cells, cholesterol can be introduced in order to achieve the optimal fluidity of the vesicle. But, in this case, what cholesterol does is actually to reduce the fluidity and increase the stability of the vehicle.
This requires a lot of care: you see, for each liposome made from a unique type of phospholipid there is a temperature (called main transition temperature) which has to be accurately known before we add cholesterol.
In fact, if we work below that temperature, the lipids will behave like a tough gel and the insertion will go terribly wrong: cholesterol will interact with the hydrophilic heads solely and disturb the order of the membrane, making the vesicle too fluid and permeable.
On the contrary, when the temperature is raised above the main transition temperature, we end up with liquid crystals. Cholesterol can therefore move freely and find its normal position in the bilayer membrane.
Generally up to 50% of cholesterol can be added.
In a nutshell, all you need to synthesize liposomes are water, the right quantity of cholesterol and the correct ionic strength. And make sure you’re working above the main transition temperature of your phospholipids(s)!
There are four types of liposomes, according to their size: SUV (small unilamellar vesicle), LUV (large unilamellar vesicle), MLV (multilamellar vesicle) and MVV (multivesicular vesicle).

LUVs are my favourite ones (fortunately I had the opportunity to talk about them during my last exam): they are simply perfect delivery systems. Larger than SUVs, they can be loaded with higher doses, but, because they are still unilamellar systems, they are synthesized using a rather simple technique called solution casting (which yields MLVs), followed by high pressure extrusion (according to the diameter of the pores SUVs or LUVs can be produced).

Solution casting begins with lipids destroyed by solvents such as dichloromethane or chloroform. This operation is carried out in a round-bottom flask: the solvent is then rapidly evaporated, leaving a film of phospholipids on the inner surface. An aqueous solution of the drug is added and, to increase the chances of yielding vesicles, glass microspheres are also employed: vesicles should form spontaneously, as the system tries to minimize its energy, but to increase the yield, you have to work this way.

PEGs cover the vesicles: as a result, the half-life is dramatically increased, because the immune system is unable to detect it. Stealth liposomes have been successfully used to parentally administer doxorubicin hydrochloride.












